speb/financial-data huggingface dataset:
Financial ratios for GENX.V — quarterly report dated 2025-01-31
Total revenue: 0
Gross profit: 0
Operating income: -35748.96551724138
Net income: -73968.27586206897
Capital expenditures: 0
Operating cash flow: -43516.551724137935
Depreciation & amortization: 195.17241379310346
Net tangible assets: -894445.5172413794
Owner earnings: -73773.10344827587
Buffett classification: The Gruesome
Stock price: 0.041379310344827586
Shares outstanding: 61224131
Book value: -889968.275862069
Market cap (USD): 2533412.317241379
Debt to equity: -0.703872435592435
Current ratio: 0.0371174386999876
Quick ratio: 0.0371174386999876
Interest coverage ratio: -1.318277765061926
Free cash flow (dilution-adjusted): -43516.551724137935
Buyback yield (%): 0
Retained earnings: -8490450.344827587
Receivables turnover: 0
Capitalized R&D asset: 0
Revenue growth (%): -100
Rule of 40 score: -100
Financial ratios for GENX.V — quarterly report dated 2025-04-30
Total revenue: 0
Gross profit: 0
Operating income: -20755.072463768116
Net income: -37666.66666666667
Capital expenditures: 0
Operating cash flow: -9001.44927536232
Depreciation & amortization: 205.07246376811597
Net tangible assets: -977277.5362318842
Owner earnings: -37461.59420289856
Buffett classification: The Gruesome
Stock price: 0.021739130434782608
Shares outstanding: 61224131
Book value: -972778.2608695653
Market cap (USD): 1330959.3695652173
Debt to equity: -0.7189016368774926
Current ratio: 0.025620888588654762
Quick ratio: 0.025620888588654762
Interest coverage ratio: -0.6918023283899328
Free cash flow (dilution-adjusted): -9001.44927536232
Buyback yield (%): 0
Retained earnings: -8958792.028985508
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GENX.V — quarterly report dated 2025-07-31
Capital expenditures: 0
Operating cash flow: -12681.884057971016
Buffett classification: The Gruesome
Stock price: 0.028985507246376815
Shares outstanding: 61224131
Market cap (USD): 1774612.4927536235
Free cash flow (dilution-adjusted): -12681.884057971016
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GENX.V — quarterly report dated 2025-10-31
Total revenue: 0
Gross profit: 0
Operating income: -23772.857142857145
Net income: -65942.14285714286
Capital expenditures: 0
Operating cash flow: -22177.14285714286
Depreciation & amortization: 202.14285714285717
Net tangible assets: -1013826.4285714286
Owner earnings: -65740
Buffett classification: The Gruesome
Stock price: 0.02142857142857143
Shares outstanding: 61224131
Book value: -1013822.8571428572
Market cap (USD): 1311945.6642857143
Debt to equity: -0.7347536058708481
Current ratio: 0.03467232341973303
Quick ratio: 0.03467232341973303
Interest coverage ratio: -0.6858308605341247
Free cash flow (dilution-adjusted): -22177.14285714286
Buyback yield (%): 0
Retained earnings: -8956395.714285715
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GENX.V — annual report dated 2025-10-31
Total revenue: 0
Gross profit: 0
Operating income: -109487.85714285714
Net income: -239325.00000000003
Capital expenditures: 0
Operating cash flow: -88621.42857142858
Depreciation & amortization: 808.5714285714287
Net tangible assets: -1013826.4285714286
Owner earnings: -238516.4285714286
Buffett classification: The Gruesome
Stock price: 0.02142857142857143
Shares outstanding: 61224131
Book value: -1013822.8571428572
Market cap (USD): 1311945.6642857143
Debt to equity: -0.7347536058708481
Current ratio: 0.03467232341973303
Quick ratio: 0.03467232341973303
Interest coverage ratio: -0.890476135148952
Free cash flow (dilution-adjusted): -88621.42857142858
Buyback yield (%): 0
Retained earnings: -8956395.714285715
Receivables turnover: 0
Capitalized R&D asset: 0
Revenue growth (%): -100
Rule of 40 score: -100
Financial ratios for GENX.V — quarterly report dated 2026-01-31
Total revenue: 0
Operating income: -17361.48148148148
Net income: -38249.62962962963
Capital expenditures: 0
Operating cash flow: -22407.407407407405
Depreciation & amortization: 0
Net tangible assets: -1089625.1851851852
Owner earnings: -38249.62962962963
Buffett classification: The Gruesome
Stock price: 0.014814814814814814
Shares outstanding: 61224131
Book value: -1089621.4814814813
Market cap (USD): 907024.1629629629
Debt to equity: -0.7331835928072883
Current ratio: 0.023390912120757442
Quick ratio: 0.023390912120757442
Interest coverage ratio: -0.5778172225920174
Free cash flow (dilution-adjusted): -22407.407407407405
Buyback yield (%): 0
Retained earnings: -9326363.703703703
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GIPCL.NS — annual report dated 2022-03-31
Total revenue: 153883344.32282737
Gross profit: 70642845.83937755
Operating income: 33616827.11327971
Net income: 22591441.382038772
Capital expenditures: 43874838.45443756
Operating cash flow: 47741896.34709218
Depreciation & amortization: 19904839.773176845
Net tangible assets: 400984491.62600553
Owner earnings: -1378557.2992219403
Return on net tangible assets (%): -0.34379317106051765
Capex to operating income (%): 130.5145137778503
Buffett classification: The Gruesome
Stock price: 0.8814453382566267
P/E ratio: 6.056026614161738
Shares outstanding: 155215944
Book value: 401478201.2396149
P/B ratio: 0.34077658472980576
Market cap (USD): 136814370.26190165
Debt to equity: 0.17366982073237724
Current ratio: 2.2318865381411763
Quick ratio: 1.670167547566042
Effective tax rate (%): 30.725368025867354
Interest coverage ratio: 9.144720510263383
COGS to revenue (%): 54.093247615428744
SG&A to revenue (%): 0.46094026775618835
Free cash flow (dilution-adjusted): 2465923.776869313
Buyback yield (%): 0
Retained earnings: 5732770.671238297
Inventory turnover: 2.8363348209712003
Receivables turnover: 3.5926002552910075
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.3616500384731545
FCF margin (%): 1.6024630785877145
Rule of 40 score: 1.6024630785877145
Financial ratios for GIPCL.NS — annual report dated 2023-03-31
Total revenue: 164259159.56151035
Gross profit: 65585371.49817296
Operating income: 29579866.01705238
Net income: 22983398.294762485
Capital expenditures: 15369817.295980513
Operating cash flow: 49970913.52009744
Depreciation & amortization: 20095164.43361754
Net tangible assets: 383870401.9488429
Owner earnings: 27708745.43239951
Return on net tangible assets (%): 7.218255247533296
Capex to operating income (%): 51.9604020083121
Buffett classification: The Good
Stock price: 0.8639464068209503
P/E ratio: 5.83457047475353
Shares outstanding: 155215944
Book value: 384201827.040195
P/B ratio: 0.34903076368268426
Market cap (USD): 134098257.10012183
Debt to equity: 0.1563938969602418
Current ratio: 3.2162509405602315
Quick ratio: 2.4316600001333915
Effective tax rate (%): 25.54531884594942
Interest coverage ratio: 6.572485223114729
COGS to revenue (%): 60.07201566521281
SG&A to revenue (%): 0.15792310612214722
Free cash flow (dilution-adjusted): 34522570.03654081
Buyback yield (%): 0
Retained earnings: 12619926.918392206
Inventory turnover: 3.130231740419818
Receivables turnover: 4.388840180686818
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.841711038846388
FCF margin (%): 21.01713543932574
Revenue growth (%): 6.742649949767056
Rule of 40 score: 27.759785389092798
Financial ratios for GIPCL.NS — annual report dated 2024-03-31
Total revenue: 160754167.1663269
Gross profit: 66703117.87984171
Operating income: 25993380.501259144
Net income: 23805096.53435664
Capital expenditures: 55351696.846144624
Operating cash flow: 67335495.8628133
Depreciation & amortization: 20132461.925890394
Net tangible assets: 396167298.2371987
Owner earnings: -11414138.385897592
Return on net tangible assets (%): -2.8811409817737057
Capex to operating income (%): 212.94535677444236
Buffett classification: The Gruesome
Stock price: 1.88207773512476
P/E ratio: 12.271677702174323
Shares outstanding: 155215944
Book value: 396391929.4879482
P/B ratio: 0.7369687690567711
Market cap (USD): 292128472.3387716
Debt to equity: 0.1858810206212211
Current ratio: 1.8654431103634577
Quick ratio: 1.5066193864055173
Effective tax rate (%): 21.387162601790216
Interest coverage ratio: 5.85996139476288
COGS to revenue (%): 58.50613451853708
SG&A to revenue (%): 0.300314278915264
Free cash flow (dilution-adjusted): 11776148.219210936
Buyback yield (%): 0
Retained earnings: 17705947.955390334
Inventory turnover: 3.5091414033850623
Receivables turnover: 4.76323790837086
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.7168208625471495
FCF margin (%): 7.325563266441828
Revenue growth (%): -2.133818536841426
Rule of 40 score: 5.191744729600402
Financial ratios for GIPCL.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 401821392.73769706
Buffett classification: The Gruesome
Stock price: 2.7028189202102246
Shares outstanding: 155215944
Book value: 402031629.240325
P/B ratio: 1.0435014552318003
Market cap (USD): 419520590.1614907
Debt to equity: 0.20668538866497702
Current ratio: 1.9646411708508416
Quick ratio: 1.506517897379832
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GIPCL.NS — quarterly report dated 2024-12-31
Total revenue: 37532206.55088005
Gross profit: 15183343.046975171
Operating income: 5413987.644247581
Net income: 4569378.7154680025
Capital expenditures: 0
Depreciation & amortization: 5012495.628861172
Owner earnings: 9581874.344329175
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.599720247115048
P/E ratio: 22.077291980959522
Shares outstanding: 155215944
Market cap (USD): 403518032.2918755
Effective tax rate (%): 26.535282112597656
Interest coverage ratio: 5.91171866050632
COGS to revenue (%): 59.54582892324205
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GIPCL.NS — annual report dated 2025-03-31
Total revenue: 146861959.31727844
Gross profit: 66027776.47884031
Operating income: 27595709.609539393
Net income: 24717570.727145195
Capital expenditures: 255384966.09773204
Operating cash flow: 71333048.86602758
Depreciation & amortization: 19883119.00865092
Net tangible assets: 411779249.4739303
Owner earnings: -210784276.3619359
Return on net tangible assets (%): -51.188659125301704
Capex to operating income (%): 925.4517086578181
Buffett classification: The Gruesome
Stock price: 2.0615007585482554
P/E ratio: 12.945357366506057
Shares outstanding: 155215944
Book value: 411948000.9352349
P/B ratio: 0.7767431461454996
Market cap (USD): 319977786.29478353
Debt to equity: 0.5751872579036197
Current ratio: 1.4917562398658912
Quick ratio: 1.1315957099693739
Effective tax rate (%): 22.53606218391091
Interest coverage ratio: 7.3917619392071945
COGS to revenue (%): 55.04092633260132
SG&A to revenue (%): 0.27542926719146366
Free cash flow (dilution-adjusted): -184681096.56301144
Buyback yield (%): 0
Retained earnings: 24162426.934767358
Inventory turnover: 2.9943837084673097
Receivables turnover: 6.278642691426909
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.408955553404102
FCF margin (%): -125.75148624023807
Revenue growth (%): -8.641895942065792
Rule of 40 score: -134.39338218230387
Financial ratios for GIPCL.NS — quarterly report dated 2025-03-31
Total revenue: 39542389.52536824
Gross profit: 19085550.61959317
Operating income: 9021884.498480242
Net income: 8151601.589899462
Capital expenditures: 0
Depreciation & amortization: 4922784.662146364
Net tangible assets: 411779249.4739303
Owner earnings: 13074386.252045825
Return on net tangible assets (%): 3.1750959449144274
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.0615007585482554
P/E ratio: 9.813341058377524
Shares outstanding: 155215944
Book value: 411948000.9352349
P/B ratio: 0.7767431461454996
Market cap (USD): 319977786.29478353
Debt to equity: 0.5751872579036197
Current ratio: 1.4917562398658912
Quick ratio: 1.1315957099693739
Effective tax rate (%): 18.45958107640351
Interest coverage ratio: 10.903403551900986
COGS to revenue (%): 51.7339471673837
Buyback yield (%): 0
Retained earnings: 24162426.934767358
Inventory turnover: 0.7577935842887611
Receivables turnover: 1.6905162926407982
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.1144922054344646
Revenue growth (%): 5.355888073788342
Rule of 40 score: 5.355888073788342
Financial ratios for GIPCL.NS — quarterly report dated 2025-06-30
Total revenue: 43473332.55324128
Gross profit: 17804013.573601685
Operating income: 7832705.35923239
Net income: 6724350.573367658
Capital expenditures: 0
Depreciation & amortization: 5351930.727825884
Owner earnings: 12076281.301193543
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.5056166627662066
P/E ratio: 20.000259087321034
Shares outstanding: 155215944
Market cap (USD): 388911655.6133864
Effective tax rate (%): 27.55542108680168
Interest coverage ratio: 9.694599330890552
COGS to revenue (%): 59.04612660693239
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 9.94108619902993
Rule of 40 score: 9.94108619902993
Financial ratios for GIPCL.NS — quarterly report dated 2025-09-30
Total revenue: 36233968.43291996
Gross profit: 16446550.169109358
Operating income: 4908872.604284104
Net income: 2400868.09470124
Capital expenditures: 0
Depreciation & amortization: 7239898.534385569
Net tangible assets: 398512717.0236753
Owner earnings: 9640766.62908681
Return on net tangible assets (%): 2.419186695242666
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.043855693348365
P/E ratio: 14.521473105165075
Shares outstanding: 155215944
Book value: 398649763.2468996
P/B ratio: 0.7957837181665711
Market cap (USD): 317238990.842841
Debt to equity: 0.7926518812064423
Current ratio: 1.548156786490071
Quick ratio: 1.0667684888565165
Effective tax rate (%): 53.97076877853092
Interest coverage ratio: 2.3945061592608887
COGS to revenue (%): 54.610132755519444
Buyback yield (%): 0
Inventory turnover: 0.7372782675760279
Receivables turnover: 1.4104586998136623
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.5385124916539389
Revenue growth (%): -16.652425050357852
Rule of 40 score: -16.652425050357852
Financial ratios for GIPCL.NS — quarterly report dated 2025-12-31
Total revenue: 41210125.87724184
Gross profit: 18250829.898629833
Operating income: 4986565.6678177565
Net income: -356700.4567227359
Capital expenditures: 0
Depreciation & amortization: 8640904.533808623
Owner earnings: 8284204.077085886
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.744569455274591
P/E ratio: 16.003727990984842
Shares outstanding: 155215944
Market cap (USD): 270784994.8740114
Effective tax rate (%): 115.09619872426488
Interest coverage ratio: 1.2385803656164485
COGS to revenue (%): 55.7127538193015
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 13.733404480754736
Rule of 40 score: 13.733404480754736
Financial ratios for HTT — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.97
Shares outstanding: 91792332
Market cap (USD): 89038562.03999999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HTT — annual report dated 2022-12-31
Total revenue: 82973184.48275863
Gross profit: 27931340.086206898
Operating income: -8703194.827586208
Net income: -52006339.51149426
Capital expenditures: 39314245.54597701
Operating cash flow: 37481531.17816092
Depreciation & amortization: 9242418.103448275
Net tangible assets: 1728880957.7586207
Owner earnings: -82078166.95402299
Return on net tangible assets (%): -4.747473594736787
Buffett classification: The Gruesome
Stock price: 0.95
Shares outstanding: 91792332
Book value: 1730274742.5287356
P/B ratio: 0.0503981901004671
Market cap (USD): 87202715.39999999
Debt to equity: 0.01262580084733683
Current ratio: 18.905727731368366
Quick ratio: 18.7061975674605
Interest coverage ratio: -17.60893286340703
COGS to revenue (%): 66.336907206435
R&D to revenue (%): 10.091092925528404
SG&A to revenue (%): 96.80953338192818
Free cash flow (dilution-adjusted): -5288714.367816092
Buyback yield (%): 24.033379449969082
Retained earnings: 1226904342.2413793
Inventory turnover: 3.2823871405348286
Receivables turnover: 0.6340729410165254
Capitalized R&D asset: 8372901.149425288
ROCI (R&D-adjusted, %): -0.17777712189403774
FCF margin (%): -6.37400432535533
Rule of 40 score: -6.37400432535533
Financial ratios for HTT — annual report dated 2023-12-31
Total revenue: 17769107.313642755
Gross profit: -4750424.191279887
Operating income: -45739649.08579465
Net income: 5504013.924050633
Capital expenditures: 79469507.5949367
Operating cash flow: 49510486.779184245
Depreciation & amortization: 5804905.063291139
Net tangible assets: 1643439932.7707453
Owner earnings: -68160588.60759492
Return on net tangible assets (%): -4.147434125729201
Buffett classification: The Gruesome
Stock price: 2.04
P/E ratio: 34.021781169875794
Shares outstanding: 91792332
Book value: 1643874960.9001408
P/B ratio: 0.1139115575904043
Market cap (USD): 187256357.28
Debt to equity: 0.005963158484063497
Current ratio: 13.466053327987352
Quick ratio: 13.452290360157399
Effective tax rate (%): 61.434931323085486
COGS to revenue (%): 126.7341746967368
R&D to revenue (%): 37.805708136784084
SG&A to revenue (%): 219.55725273702117
Free cash flow (dilution-adjusted): -30653223.628691982
Buyback yield (%): 31.59549041523203
Retained earnings: 1206524298.3122363
Inventory turnover: 15.419339762734156
Receivables turnover: 0.35662129643574525
Capitalized R&D asset: 12327580.619622678
ROCI (R&D-adjusted, %): -2.650876738099421
Rosenberg metric: -3.9032784090291153
FCF margin (%): -172.50851766288264
Revenue growth (%): -78.58451808929296
Rule of 40 score: -251.09303575217558
Financial ratios for HTT — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.13
Shares outstanding: 91792332
Market cap (USD): 195517667.16
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HTT — annual report dated 2024-12-31
Total revenue: 29647722.465753425
Gross profit: 2110315.205479452
Operating income: -41996960.82191781
Net income: 12565944.520547945
Capital expenditures: 43561448.90410959
Operating cash flow: -15205510.684931507
Depreciation & amortization: 7597999.041095891
Net tangible assets: 1546468735.7534246
Owner earnings: -23397505.342465755
Return on net tangible assets (%): -1.512963359784103
Buffett classification: The Gruesome
Stock price: 2.82
P/E ratio: 20.59967524261459
Shares outstanding: 91792332
Book value: 1546771100
P/B ratio: 0.16735144342947705
Market cap (USD): 258854376.23999998
Debt to equity: 0.06973457760819846
Current ratio: 9.020187520969088
Quick ratio: 9.010691842648813
Effective tax rate (%): 41.77153016823005
COGS to revenue (%): 92.8820326488245
R&D to revenue (%): 27.013247810104602
SG&A to revenue (%): 130.497179635051
Free cash flow (dilution-adjusted): -59076246.57534247
Buyback yield (%): 28.214755377896523
Retained earnings: 1187687555.6164384
Inventory turnover: 18.83293367127543
Receivables turnover: 0.8135996555511282
Capitalized R&D asset: 15272753.808206556
ROCI (R&D-adjusted, %): -2.6574578986371797
Rosenberg metric: 1.0212873100651572
FCF margin (%): -199.26065701533201
Revenue growth (%): 66.84981379447528
Rule of 40 score: -132.41084322085675
Financial ratios for HTT — quarterly report dated 2024-12-31
Total revenue: 7155667.671232877
Gross profit: 604150.8219178083
Operating income: -15212029.315068493
Net income: -9090356.84931507
Capital expenditures: 0
Net tangible assets: 1546468735.7534246
Owner earnings: -9090356.84931507
Return on net tangible assets (%): -0.5878138134416494
Buffett classification: The Gruesome
Stock price: 2.82
Shares outstanding: 91792332
Book value: 1546771100
P/B ratio: 0.16735144342947705
Market cap (USD): 258854376.23999998
Debt to equity: 0.06973457760819846
Current ratio: 9.020187520969088
Quick ratio: 9.010691842648813
COGS to revenue (%): 91.55703073877218
R&D to revenue (%): 24.535265407204566
SG&A to revenue (%): 222.34492003598868
Buyback yield (%): 0
Retained earnings: 1187687555.6164384
Inventory turnover: 4.480606365850235
Receivables turnover: 0.19636748688801733
Capitalized R&D asset: 1755662.0547945206
ROCI (R&D-adjusted, %): -0.9028805663757457
Rule of 40 score: 0
Financial ratios for HTT — quarterly report dated 2025-03-31
Total revenue: 3552203.8567493116
Gross profit: -61983.47107438017
Operating income: -8583195.592286501
Net income: 20675619.834710743
Capital expenditures: 0
Net tangible assets: 1564277548.2093663
Owner earnings: 20675619.834710743
Return on net tangible assets (%): 1.3217360217423175
Buffett classification: The Gruesome
Stock price: 2.69
P/E ratio: 2.9856586532107525
Shares outstanding: 91792332
Book value: 1564561845.7300274
P/B ratio: 0.15782142058103563
Market cap (USD): 246921373.07999998
Debt to equity: 0.06636399755993612
Current ratio: 8.146384644567483
Quick ratio: 8.146384644567483
Effective tax rate (%): 0.0059954434629681435
COGS to revenue (%): 101.74493000891853
R&D to revenue (%): 50.657256970025976
SG&A to revenue (%): 193.07456667571444
Buyback yield (%): 0
Retained earnings: 1214906887.0523417
Receivables turnover: 1.7115078311653837
Capitalized R&D asset: 2975742.612525001
ROCI (R&D-adjusted, %): -0.5074359320771229
Rosenberg metric: -0.3794205673996591
Revenue growth (%): -50.358177322434415
Rule of 40 score: -50.358177322434415
Financial ratios for HTT — quarterly report dated 2025-06-30
Total revenue: 486750.3486750349
Gross profit: 74476.98744769875
Operating income: -10700278.940027894
Net income: 43481450.488145046
Capital expenditures: 0
Net tangible assets: 1614622594.1422594
Owner earnings: 43481450.488145046
Return on net tangible assets (%): 2.692979191911025
Buffett classification: The Gruesome
Stock price: 3.14
P/E ratio: 5.234158792107542
Shares outstanding: 91792332
Book value: 1614890655.5090656
P/B ratio: 0.1784813860286666
Market cap (USD): 288227922.48
Debt to equity: 0.06326045452511951
Current ratio: 9.132706951554987
Quick ratio: 9.132706951554987
Effective tax rate (%): 9.708268290069306
COGS to revenue (%): 84.69914040114612
R&D to revenue (%): 324.67048710601716
SG&A to revenue (%): 1906.1318051575927
Buyback yield (%): 0
Retained earnings: 1273638214.7838216
Receivables turnover: 0.37831978319783194
Capitalized R&D asset: 3365334.060110155
ROCI (R&D-adjusted, %): -0.6674750515397337
Rosenberg metric: 0.07583457814377625
Revenue growth (%): -86.29722931722536
Rule of 40 score: -86.29722931722536
Financial ratios for HTT — quarterly report dated 2025-09-30
Total revenue: 1197050.5617977527
Gross profit: 277247.19101123593
Operating income: -13717556.17977528
Net income: 57570646.06741573
Capital expenditures: 0
Net tangible assets: 1678364887.6404495
Owner earnings: 57570646.06741573
Return on net tangible assets (%): 3.4301626834169623
Buffett classification: The Gruesome
Stock price: 4.27
P/E ratio: 3.47978023665834
Shares outstanding: 91792332
Book value: 1678614747.1910112
P/B ratio: 0.23349804253530676
Market cap (USD): 391953257.64
Debt to equity: 0.13275082944010566
Current ratio: 5.827730639993709
Quick ratio: 5.827730639993709
Effective tax rate (%): -2.930703710399968
COGS to revenue (%): 76.83914114748328
R&D to revenue (%): 130.25929836911888
SG&A to revenue (%): 1036.735891118151
Buyback yield (%): 0
Retained earnings: 1340152949.4382021
Receivables turnover: 1.3154807840716158
Capitalized R&D asset: 3211912.1125219567
ROCI (R&D-adjusted, %): -0.8205469682211667
Rosenberg metric: 0.12830838933461844
Revenue growth (%): 145.92700653552683
Rule of 40 score: 145.92700653552683
Financial ratios for IRIX — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 6.11
Shares outstanding: 17406518
Market cap (USD): 106353824.98
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IRIX — annual report dated 2022-12-31
Total revenue: 56972000
Gross profit: 25368000
Operating income: -7542000
Net income: -7547000
Capital expenditures: 286000
Operating cash flow: -9519000
Depreciation & amortization: 1384000
Net tangible assets: 14289000
Owner earnings: -6449000
Return on net tangible assets (%): -45.13261949751557
Buffett classification: The Gruesome
Stock price: 2.01
Shares outstanding: 17406518
Book value: 17231000
P/B ratio: 2.0304742139167775
Market cap (USD): 34987101.18
Debt to equity: 0.10266380360977308
Current ratio: 2.872079017104312
Quick ratio: 2.0202360876897134
COGS to revenue (%): 55.47286386295022
R&D to revenue (%): 12.593905778277048
SG&A to revenue (%): 45.17131222354841
Free cash flow (dilution-adjusted): -11426000
Buyback yield (%): 0
Retained earnings: -69716000
Inventory turnover: 2.979260935143288
Receivables turnover: 5.832514332514332
Capitalized R&D asset: 7175000
ROCI (R&D-adjusted, %): -7.4534385244425225
FCF margin (%): -20.05546584287018
Rule of 40 score: -20.05546584287018
Financial ratios for IRIX — annual report dated 2023-12-31
Total revenue: 51869000
Gross profit: 21807000
Operating income: -10007000
Net income: -9570000
Capital expenditures: 109000
Operating cash flow: -6745000
Depreciation & amortization: 2032000
Net tangible assets: 6915000
Owner earnings: -7647000
Return on net tangible assets (%): -110.58568329718004
Buffett classification: The Gruesome
Stock price: 2.81
Shares outstanding: 17406518
Book value: 9522000
P/B ratio: 5.136769122033186
Market cap (USD): 48912315.58
Debt to equity: 0.28838479311069104
Current ratio: 2.1157700015415446
Quick ratio: 1.3522429474333282
COGS to revenue (%): 57.9575468969905
R&D to revenue (%): 13.16586014767973
SG&A to revenue (%): 48.16942682527136
Free cash flow (dilution-adjusted): -8504000
Buyback yield (%): 0
Retained earnings: -79042000
Inventory turnover: 3.034726428427216
Receivables turnover: 5.372798839859126
Capitalized R&D asset: 11636250
ROCI (R&D-adjusted, %): -23.70518078750387
Rosenberg metric: -0.49630662020905925
FCF margin (%): -16.39514931847539
Revenue growth (%): -8.95703152425753
Rule of 40 score: -25.35218084273292
Financial ratios for IRIX — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.75
Shares outstanding: 17406518
Market cap (USD): 30461406.5
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IRIX — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.68
Shares outstanding: 17406518
Market cap (USD): 29242950.24
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IRIX — annual report dated 2024-12-31
Total revenue: 48669000
Gross profit: 19502000
Operating income: -8302000
Net income: -8910000
Capital expenditures: 13000
Operating cash flow: -7285000
Depreciation & amortization: 1424000
Net tangible assets: -174000
Owner earnings: -7499000
Buffett classification: The Gruesome
Stock price: 1.68
Shares outstanding: 17406518
Book value: 2097000
P/B ratio: 13.945136022889843
Market cap (USD): 29242950.24
Debt to equity: 2.2141154029566046
Current ratio: 1.422912011594903
Quick ratio: 0.7696720816474425
COGS to revenue (%): 59.92931845733423
R&D to revenue (%): 11.196038546097105
SG&A to revenue (%): 45.93272925270706
Free cash flow (dilution-adjusted): -8541000
Buyback yield (%): 0
Retained earnings: -88009000
Inventory turnover: 2.696403808819451
Receivables turnover: 5.79807005003574
Capitalized R&D asset: 12392180
ROCI (R&D-adjusted, %): -37.396932148572034
Rosenberg metric: -0.3375311172938937
FCF margin (%): -17.549158601984836
Revenue growth (%): -6.169388266594691
Rule of 40 score: -23.718546868579526
Financial ratios for IRIX — quarterly report dated 2025-03-31
Total revenue: 11896000
Gross profit: 5055000
Operating income: -205000
Net income: -1686000
Capital expenditures: 11000
Operating cash flow: -1149000
Depreciation & amortization: 381000
Net tangible assets: -1336000
Owner earnings: -1316000
Buffett classification: The Gruesome
Stock price: 0.99
Shares outstanding: 17406518
Book value: 852000
P/B ratio: 20.225883591549294
Market cap (USD): 17232452.82
Debt to equity: 6.219483568075117
Current ratio: 1.9488191610356593
Quick ratio: 1.2702883521776944
COGS to revenue (%): 57.50672494956288
R&D to revenue (%): 7.363819771351715
SG&A to revenue (%): 36.852723604572965
Free cash flow (dilution-adjusted): -1373000
Buyback yield (%): 0
Retained earnings: -89695000
Inventory turnover: 0.6745217905738513
Receivables turnover: 1.2674195610483698
Capitalized R&D asset: 876000
ROCI (R&D-adjusted, %): 1.8794941730721548
FCF margin (%): -11.541694687289846
Rule of 40 score: -11.541694687289846
Financial ratios for IRIX — quarterly report dated 2025-06-30
Total revenue: 13571000
Gross profit: 4682000
Operating income: -940000
Net income: -994000
Capital expenditures: 13000
Operating cash flow: -397000
Depreciation & amortization: 378000
Net tangible assets: 3950000
Owner earnings: -629000
Return on net tangible assets (%): -15.924050632911394
Buffett classification: The Gruesome
Stock price: 0.88
Shares outstanding: 17406518
Book value: 6059000
P/B ratio: 2.5280963591351706
Market cap (USD): 15317735.84
Debt to equity: 0.8364416570391153
Current ratio: 1.9598803705594865
Quick ratio: 1.3445911445036107
COGS to revenue (%): 65.49996315673127
R&D to revenue (%): 6.418097413602535
SG&A to revenue (%): 35.008473951809
Free cash flow (dilution-adjusted): -667000
Buyback yield (%): 0
Retained earnings: -90689000
Inventory turnover: 1.0538233550681684
Receivables turnover: 1.3530408773678964
Capitalized R&D asset: 1457920
ROCI (R&D-adjusted, %): -3.3688632896656934
Rosenberg metric: -0.4257990867579909
FCF margin (%): -4.914892049222607
Revenue growth (%): 14.080363147276396
Rule of 40 score: 9.16547109805379
Financial ratios for IRIX — quarterly report dated 2025-09-30
Total revenue: 12484000
Gross profit: 4013000
Operating income: -1411000
Net income: -1573000
Capital expenditures: 13000
Operating cash flow: -1158000
Depreciation & amortization: 366000
Net tangible assets: 2652000
Owner earnings: -1220000
Return on net tangible assets (%): -46.003016591251885
Buffett classification: The Gruesome
Stock price: 1.14
Shares outstanding: 17406518
Book value: 4681000
P/B ratio: 4.239143456526383
Market cap (USD): 19843430.52
Debt to equity: 1.022217474898526
Current ratio: 1.9420593931568755
Quick ratio: 1.3528889606197547
COGS to revenue (%): 67.85485421339314
R&D to revenue (%): 7.785966036526753
SG&A to revenue (%): 35.66164690804229
Free cash flow (dilution-adjusted): -1263000
Buyback yield (%): 0
Retained earnings: -92262000
Inventory turnover: 1.1602520202711957
Receivables turnover: 1.3099685204617
Capitalized R&D asset: 1844650
ROCI (R&D-adjusted, %): -7.555654150976424
Rosenberg metric: -0.7680826636050516
FCF margin (%): -10.116949695610382
Revenue growth (%): -8.009726622945989
Rule of 40 score: -18.12667631855637
Financial ratios for IRIX — quarterly report dated 2025-12-31
Total revenue: 21273000
Gross profit: 5477000
Operating income: -15000
Net income: -184000
Capital expenditures: 106000
Operating cash flow: 589000
Depreciation & amortization: 422000
Net tangible assets: 2973000
Owner earnings: 132000
Buffett classification: The Gruesome
Stock price: 1.14
Shares outstanding: 17406518
Book value: 4922000
P/B ratio: 4.031578732222673
Market cap (USD): 19843430.52
Debt to equity: 0.9207639171068671
Current ratio: 1.9118715929739551
Quick ratio: 1.3154906117504543
COGS to revenue (%): 43.46824613359658
R&D to revenue (%): 4.461053918112161
SG&A to revenue (%): 21.35570911484041
Free cash flow (dilution-adjusted): 270000
Buyback yield (%): 0
Retained earnings: -92446000
Inventory turnover: 1.1739240827726292
Receivables turnover: 2.228706128863279
Capitalized R&D asset: 1887670
ROCI (R&D-adjusted, %): 0.018694380712185085
Rosenberg metric: 1.5061728395061729
FCF margin (%): 1.2692144972500352
Revenue growth (%): 70.40211470682473
Rule of 40 score: 71.67132920407477
Financial ratios for IRIX — annual report dated 2025-12-31
Total revenue: 52675000
Gross profit: 19227000
Operating income: -2571000
Net income: -4437000
Capital expenditures: 143000
Operating cash flow: -2115000
Depreciation & amortization: 1547000
Net tangible assets: 2973000
Owner earnings: -3033000
Return on net tangible assets (%): -102.01816347124118
Buffett classification: The Gruesome
Stock price: 1.14
Shares outstanding: 17406518
Book value: 4922000
P/B ratio: 4.031578732222673
Market cap (USD): 19843430.52
Debt to equity: 0.9207639171068671
Current ratio: 1.9118715929739551
Quick ratio: 1.3154906117504543
COGS to revenue (%): 63.498813478879924
R&D to revenue (%): 6.9634551495016614
SG&A to revenue (%): 34.418604651162795
Free cash flow (dilution-adjusted): -3033000
Buyback yield (%): 0
Retained earnings: -92446000
Inventory turnover: 4.246286657356862
Receivables turnover: 5.518596123624935
Capitalized R&D asset: 9572400
ROCI (R&D-adjusted, %): -16.532499327203702
Rosenberg metric: -0.050467975775371626
FCF margin (%): -5.757949691504509
Revenue growth (%): 8.231112206948982
Rule of 40 score: 2.473162515444473
Financial ratios for JBTM — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 151.15
Shares outstanding: 52067812
Market cap (USD): 7870049783.8
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for JBTM — annual report dated 2022-12-31
Total revenue: 1590300000
Gross profit: 529400000
Operating income: 139700000
Net income: 137400000
Capital expenditures: 84600000
Operating cash flow: 135200000
Depreciation & amortization: 76200000
Net tangible assets: -380600000
Owner earnings: 129000000
Return on net tangible assets (%): -33.893851812926954
Capex to operating income (%): 60.558339298496776
Buffett classification: The Good
Stock price: 90.23
P/E ratio: 34.192712349053856
Shares outstanding: 52067812
Book value: 905400000
P/B ratio: 5.188953696443561
Market cap (USD): 4698078676.76
Debt to equity: 1.0800751049259996
Current ratio: 1.484775641025641
Quick ratio: 1.0616987179487178
Effective tax rate (%): 13.5
Interest coverage ratio: 8.570552147239264
COGS to revenue (%): 66.71068351883292
SG&A to revenue (%): 27.787209960384835
Free cash flow (dilution-adjusted): 41700000
Buyback yield (%): 0.16389678695866913
Retained earnings: 894000000
Inventory turnover: 4.018560606060606
Receivables turnover: 5.987575301204819
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.926127912741696
FCF margin (%): 2.622146764761366
Rule of 40 score: 2.622146764761366
Financial ratios for JBTM — annual report dated 2023-12-31
Total revenue: 1664400000
Gross profit: 585700000
Operating income: 176100000
Net income: 582600000
Capital expenditures: 55100000
Operating cash flow: 74200000
Depreciation & amortization: 91300000
Net tangible assets: 251400000
Owner earnings: 618800000
Return on net tangible assets (%): 246.14160700079552
Capex to operating income (%): 31.28904031800114
Buffett classification: The Good
Stock price: 98.62
P/E ratio: 8.813813284311706
Shares outstanding: 52067812
Book value: 1488900000
P/B ratio: 3.4488062458459265
Market cap (USD): 5134927619.440001
Debt to equity: 0.43414601383571766
Current ratio: 2.2712634186622624
Quick ratio: 1.778075970272502
Effective tax rate (%): 15.349444807315479
Interest coverage ratio: 7.246913580246914
COGS to revenue (%): 64.81014179283827
SG&A to revenue (%): 24.609468877673635
Free cash flow (dilution-adjusted): 7700000
Buyback yield (%): 0.09931980308139554
Retained earnings: 1463600000
Inventory turnover: 4.5152783591460866
Receivables turnover: 5.761163032191069
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.9110512129380055
FCF margin (%): 0.4626291756789233
Revenue growth (%): 4.659498207885305
Rule of 40 score: 5.122127383564228
Financial ratios for JBTM — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 98
Shares outstanding: 52067812
Market cap (USD): 5102645576
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for JBTM — annual report dated 2024-12-31
Total revenue: 1716000000
Gross profit: 626500000
Operating income: 119800000
Net income: 85400000
Capital expenditures: 37900000
Operating cash flow: 232600000
Depreciation & amortization: 89400000
Net tangible assets: 372600000
Owner earnings: 136900000
Return on net tangible assets (%): 36.741814278046164
Capex to operating income (%): 31.636060100166947
Buffett classification: The Good
Stock price: 126.54
P/E ratio: 77.15059637564403
Shares outstanding: 52067812
Book value: 1544200000
P/B ratio: 4.266714758761818
Market cap (USD): 6588660930.4800005
Debt to equity: 0.8108405646936925
Current ratio: 3.4795518207282914
Quick ratio: 3.0442577030812323
Effective tax rate (%): 11.215932914046121
Interest coverage ratio: 6.175257731958763
COGS to revenue (%): 63.490675990675996
SG&A to revenue (%): 29.527972027972027
Free cash flow (dilution-adjusted): 180000000
Buyback yield (%): 0
Retained earnings: 1535900000
Inventory turnover: 4.673959673959674
Receivables turnover: 5.120859444941808
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.162179064030851
FCF margin (%): 10.48951048951049
Revenue growth (%): 3.1002162941600577
Rule of 40 score: 13.589726783670548
Financial ratios for JBTM — quarterly report dated 2024-12-31
Total revenue: 467600000
Gross profit: 179400000
Operating income: 16000000
Net income: -7000000
Capital expenditures: 10000000
Operating cash flow: 128700000
Depreciation & amortization: 22900000
Net tangible assets: 372600000
Owner earnings: 5900000
Capex to operating income (%): 62.5
Buffett classification: The Good
Stock price: 126.54
Shares outstanding: 52067812
Book value: 1544200000
P/B ratio: 4.266714758761818
Market cap (USD): 6588660930.4800005
Debt to equity: 0.8108405646936925
Current ratio: 3.4795518207282914
Quick ratio: 3.0442577030812323
Interest coverage ratio: 1.927710843373494
COGS to revenue (%): 61.633875106929004
SG&A to revenue (%): 34.944396920444824
Free cash flow (dilution-adjusted): 115400000
Buyback yield (%): 0
Retained earnings: 1535900000
Inventory turnover: 1.2363792363792363
Receivables turnover: 1.3954043569083856
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.5558836813396797
FCF margin (%): 24.679213002566296
Rule of 40 score: 24.679213002566296
Financial ratios for JBTM — quarterly report dated 2025-03-31
Total revenue: 854000000
Gross profit: 292000000
Operating income: -33000000
Net income: -173000000
Capital expenditures: 20000000
Operating cash flow: 34000000
Depreciation & amortization: 61000000
Net tangible assets: -1348700000
Owner earnings: -132000000
Buffett classification: The Gruesome
Stock price: 121.75
Shares outstanding: 52067812
Book value: 4107300000
P/B ratio: 1.5434120008277945
Market cap (USD): 6339256111
Debt to equity: 0.4838945292527938
Current ratio: 1.2578164610444482
Quick ratio: 0.7393949636640189
Interest coverage ratio: -0.8048780487804879
COGS to revenue (%): 65.807962529274
R&D to revenue (%): 3.934426229508197
SG&A to revenue (%): 38.05620608899297
Free cash flow (dilution-adjusted): 9000000
Buyback yield (%): 0
Retained earnings: 1358000000
Inventory turnover: 0.9160554197229014
Receivables turnover: 1.5701415701415702
Capitalized R&D asset: 33600000
ROCI (R&D-adjusted, %): -0.154755821592817
FCF margin (%): 1.053864168618267
Revenue growth (%): 82.63473053892216
Rule of 40 score: 83.68859470754042
Financial ratios for JBTM — quarterly report dated 2025-06-30
Total revenue: 934800000
Gross profit: 334200000
Operating income: 52900000
Net income: 3400000
Capital expenditures: 18500000
Operating cash flow: 102600000
Depreciation & amortization: 82100000
Net tangible assets: -1297900000
Owner earnings: 67000000
Return on net tangible assets (%): -5.162185068187072
Capex to operating income (%): 34.97164461247637
Buffett classification: The Good
Stock price: 119.92
P/E ratio: 459.1155893411765
Shares outstanding: 52067812
Book value: 4374900000
P/B ratio: 1.4272262257514456
Market cap (USD): 6243972015.04
Debt to equity: 0.4392100390866077
Current ratio: 0.9302184096854658
Quick ratio: 0.5280160613250593
Effective tax rate (%): 68.10344827586206
Interest coverage ratio: 1.6635220125786163
COGS to revenue (%): 64.24903722721437
R&D to revenue (%): 3.305519897304236
SG&A to revenue (%): 26.7864783910997
Free cash flow (dilution-adjusted): 79800000
Buyback yield (%): 0
Retained earnings: 1356200000
Inventory turnover: 0.908485856905158
Receivables turnover: 1.7240870527480634
Capitalized R&D asset: 53412000
ROCI (R&D-adjusted, %): 0.9351108143839555
Rosenberg metric: 1.255952380952381
FCF margin (%): 8.536585365853659
Revenue growth (%): 9.46135831381733
Rule of 40 score: 17.99794367967099
Financial ratios for JBTM — quarterly report dated 2025-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 140.16
Shares outstanding: 52067812
Market cap (USD): 7297824529.92
Buyback yield (%): 0
Capitalized R&D asset: 31791000
Rule of 40 score: 0
Financial ratios for JBTM — annual report dated 2025-12-31
Total revenue: 3798200000
Gross profit: 1334600000
Operating income: 218700000
Net income: -50500000
Capital expenditures: 103600000
Operating cash flow: 341700000
Depreciation & amortization: 266200000
Net tangible assets: -1189900000
Owner earnings: 112100000
Capex to operating income (%): 47.3708276177412
Buffett classification: The Good
Stock price: 150.45
Shares outstanding: 52067812
Book value: 4463800000
P/B ratio: 1.7549178537120835
Market cap (USD): 7833602315.4
Debt to equity: 0.4215914691518437
Current ratio: 0.9758969300949328
Quick ratio: 0.5790901245222537
Interest coverage ratio: 1.9117132867132867
COGS to revenue (%): 64.86230319625086
SG&A to revenue (%): 29.37970617660997
Free cash flow (dilution-adjusted): 214900000
Buyback yield (%): 0
Retained earnings: 1464800000
Inventory turnover: 3.827248718347056
Receivables turnover: 6.765586034912718
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.3295272893354646
FCF margin (%): 5.657943236269812
Revenue growth (%): 121.34032634032634
Rule of 40 score: 126.99826957659616
Financial ratios for JBTM — quarterly report dated 2025-12-31
Total revenue: 1008000000
Gross profit: 348100000
Operating income: 79500000
Net income: 53100000
Capital expenditures: 33900000
Operating cash flow: 117400000
Depreciation & amortization: 67700000
Net tangible assets: -1189900000
Owner earnings: 86900000
Return on net tangible assets (%): -7.303134717203126
Capex to operating income (%): 42.64150943396226
Buffett classification: The Good
Stock price: 150.45
P/E ratio: 36.88136683333333
Shares outstanding: 52067812
Book value: 4463800000
P/B ratio: 1.7549178537120835
Market cap (USD): 7833602315.4
Debt to equity: 0.4215914691518437
Current ratio: 0.9758969300949328
Quick ratio: 0.5790901245222537
Effective tax rate (%): 13.170731707317074
Interest coverage ratio: 5.129032258064516
COGS to revenue (%): 65.46626984126985
SG&A to revenue (%): 35.892857142857146
Free cash flow (dilution-adjusted): 77400000
Buyback yield (%): 0
Retained earnings: 1464800000
Inventory turnover: 1.0251670032623894
Receivables turnover: 1.7955112219451372
Capitalized R&D asset: 10197000
ROCI (R&D-adjusted, %): 1.0518800303464348
FCF margin (%): 7.678571428571429
Rule of 40 score: 7.678571428571429
Financial ratios for KROS — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 58.51
Shares outstanding: 19791837
Market cap (USD): 1158020382.87
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for KROS — annual report dated 2022-12-31
Total revenue: 0
Operating income: -107709000
Net income: -104679000
Capital expenditures: 1241000
Operating cash flow: -70062000
Depreciation & amortization: 674000
Net tangible assets: 277423000
Owner earnings: -105246000
Return on net tangible assets (%): -37.93701315319927
Buffett classification: The Gruesome
Stock price: 48.02
Shares outstanding: 19791837
Book value: 277423000
P/B ratio: 3.4258299158325016
Market cap (USD): 950404012.74
Debt to equity: 0.04781867401044614
Current ratio: 17.27001873451381
Quick ratio: 17.27001873451381
Interest coverage ratio: -107709
Free cash flow (dilution-adjusted): -89985000
Buyback yield (%): 0
Retained earnings: -228434000
Receivables turnover: 0
Capitalized R&D asset: 87265000
ROCI (R&D-adjusted, %): -13.121182660969518
Rule of 40 score: 0
Financial ratios for KROS — annual report dated 2023-12-31
Total revenue: 151000
Operating income: -167541000
Net income: -152992000
Capital expenditures: 2464000
Operating cash flow: -124508000
Depreciation & amortization: 815000
Net tangible assets: 332213000
Owner earnings: -154641000
Return on net tangible assets (%): -46.5487503499261
Buffett classification: The Gruesome
Stock price: 39.76
Shares outstanding: 19791837
Book value: 332213000
P/B ratio: 2.3687316243494383
Market cap (USD): 786923439.12
Debt to equity: 0.0434781299949129
Current ratio: 14.24908710458294
Quick ratio: 14.24908710458294
COGS to revenue (%): 0
R&D to revenue (%): 89574.83443708609
SG&A to revenue (%): 23068.87417218543
Free cash flow (dilution-adjusted): -155735000
Buyback yield (%): 0
Retained earnings: -381426000
Receivables turnover: 0.1384051329055912
Capitalized R&D asset: 193725550
ROCI (R&D-adjusted, %): -19.737071617706988
FCF margin (%): -103135.76158940398
Rule of 40 score: -103135.76158940398
Financial ratios for KROS — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 58.07
Shares outstanding: 19791837
Market cap (USD): 1149311974.59
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for KROS — annual report dated 2024-12-31
Total revenue: 3550000
Operating income: -209595000
Net income: -187353000
Capital expenditures: 1931000
Operating cash flow: -160869000
Depreciation & amortization: 1229000
Net tangible assets: 571553000
Owner earnings: -188055000
Return on net tangible assets (%): -32.90246048922847
Buffett classification: The Gruesome
Stock price: 15.83
Shares outstanding: 19791837
Book value: 571553000
P/B ratio: 0.5481640017811121
Market cap (USD): 313304779.71
Debt to equity: 0.0329995643448639
Current ratio: 21.45329690346084
Quick ratio: 21.45329690346084
COGS to revenue (%): 0
R&D to revenue (%): 4890.957746478874
SG&A to revenue (%): 1148
Free cash flow (dilution-adjusted): -197672000
Buyback yield (%): 0
Retained earnings: -568779000
Receivables turnover: 0.7966786355475763
Capitalized R&D asset: 293049310
ROCI (R&D-adjusted, %): -19.060631500105963
FCF margin (%): -5568.225352112676
Revenue growth (%): 2250.9933774834435
Rule of 40 score: -3317.2319746292324
Financial ratios for KROS — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 15.83
Shares outstanding: 19791837
Market cap (USD): 313304779.71
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for KROS — quarterly report dated 2025-03-31
Total revenue: 11472655.19
Operating income: 152040000
Net income: 148451000
Capital expenditures: 565000
Operating cash flow: 161171000
Depreciation & amortization: 344000
Net tangible assets: 728871000
Owner earnings: 148230000
Return on net tangible assets (%): 20.336932049704266
Capex to operating income (%): 0.3716127334911865
Buffett classification: The Great
Stock price: 10.19
P/E ratio: 0.3396387006992206
Shares outstanding: 19791837
Book value: 728871000
P/B ratio: 0.276700292685537
Market cap (USD): 201678819.03
Debt to equity: 0.025262357810915785
Current ratio: 19.28715812996775
Quick ratio: 19.28715812996775
Effective tax rate (%): 6.336517470692897
COGS to revenue (%): 0
R&D to revenue (%): 424.56605897522843
SG&A to revenue (%): 91.49582050674357
Free cash flow (dilution-adjusted): 151743000
Buyback yield (%): 0
Retained earnings: -420328000
Receivables turnover: 0.592167605553835
Capitalized R&D asset: 48709000
ROCI (R&D-adjusted, %): 23.241561708933173
FCF margin (%): 1322.6493561164893
Rule of 40 score: 1322.6493561164893